Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.6 USD | -4.64% | -12.24% | +135.29% |
28/05 | Johnson & Johnson Acquires Experimental Eczema Drug for $1.25 Billion | MT |
15/05 | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARCUTIS BIOTHERAPEUTICS, INC. | Bio Therapeutic Drugs | -4.64% | -12.24% | +135.29% | -11.83% | - | 92Cr |
- Stock Market
- Equities
- ARQT Stock
- Charts Arcutis Biotherapeutics, Inc.
- Relative Strength Chart